Press "Enter" to skip to content

Chemo Regimen Boosts Gefitinib in EGFR-Mutant Lung Cancer, But at What Cost? – Cancer Network

admin 0

Chemo Regimen Boosts Gefitinib in EGFR-Mutant Lung Cancer, But at What Cost?  Cancer Network

Addition of a pemetrexed-carboplatin chemotherapy regimen to gefitinib led to a survival benefit in patients with EGFR-mutant advanced non–small-cell lung …

“lung cancer” – Google News

(Visited 3 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *